LN4756449
AKTinhibitorVIII , ≥98%
Synonym(s):
1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one trifluoroacetate salt hydrate;Akt Inhibitor VIII trifluoroacetate salt hydrate;Akti-1/2 trifluoroacetate salt hydrate
| Pack Size | Price | Stock | Quantity |
| 10mM(in1mLDMSO) | RMB1031.20 | In Stock |
|
| 10mg | RMB1151.20 | In Stock |
|
| 25mg | RMB2791.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | >255oC (dec.) |
| storage temp. | 2-8°C |
| solubility | DMSO (Slightly) |
| form | powder |
| color | yellow |
Description and Uses
Akt plays a role in signal transduction pathways of cell proliferation, apoptosis, angiogenesis, and diabetes. Akt1 and Akt2 dual kinase inhibitors are capable of sensitizing tumor cells to certain apoptotic stimuli, and inhibit Akt phosphorylation in vivo. Akt1 kinase activity and its regulation by extracellular signaling factors in vivo in hematopoietic cells suggests the activation of AKT1 involves intracellular translocation of the kinase from cytosol to membrane.
Safety
| WGK Germany | 3 |